Yanlin Han

Fondatore presso Shanxi Tongling Pharmaceutical Co.

60 anni

Health Technology

Consumer Services

Posizioni attive di Yanlin Han

Società	Posizione	Inizio	Fine
Dragon Pharmaceutical, Inc. Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada.	Presidente	-	-
	Presidente	12/01/2005	-
	Amministratore Delegato	12/01/2005	-
Shanxi Province Foreign Investment Enterprise Association	Corporate Officer/Principal	-	-
Datong City Trade Council	Corporate Officer/Principal	-	-
Oriental Wave Holding Ltd. Oriental Wave Holding Ltd. Pharmaceuticals: MajorHealth Technology Part of Datong Investment, Inc., Oriental Wave Holding Ltd. develops pharmaceuticals. Oriental Wave Holding was acquired by Dragon Pharmaceutical, Inc., part of Datong Investment, Inc. from July 22, 2010 on January 12, 2005.	Presidente	-	-
Shanxi Tongling Pharmaceutical Co.	Fondatore	28/04/2011	-
Shanxi Tongling Pharmaceutical Co.	Corporate Officer/Principal	01/01/1994	28/04/2011

Shanxi University of Finance & Economics

Undergraduate Degree

Distribuzione geografica

Canada	4
Cina	4

Posizioni

Corporate Officer/Principal	3
Chairman	2
Chief Executive Officer	1

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	5
Dragon Pharmaceutical, Inc. Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada.	Health Technology
Oriental Wave Holding Ltd. Oriental Wave Holding Ltd. Pharmaceuticals: MajorHealth Technology Part of Datong Investment, Inc., Oriental Wave Holding Ltd. develops pharmaceuticals. Oriental Wave Holding was acquired by Dragon Pharmaceutical, Inc., part of Datong Investment, Inc. from July 22, 2010 on January 12, 2005.	Health Technology
Shanxi Province Foreign Investment Enterprise Association
Datong City Trade Council
Shanxi Tongling Pharmaceutical Co.